查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611505

口服注射器市場規模、佔有率、趨勢分析報告：按類型、按用途、按最終用途、按地區、細分市場預測，2025-2030 年

Oral Syringes Market Size, Share & Trends Analysis Report By Type, By Usage, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

口腔注射器市場成長與趨勢

根據Grand View Research, Inc.最新報告，預計2030年全球口腔注射器市場規模將達10.5億美元，2025年至2030年複合年成長率為6.1%。

推動市場成長的因素包括呼吸系統疾病盛行率的增加、兒童癌症發生率的增加、技術進步和政府措施。慢性阻塞性肺病盛行率的上升是推動市場成長的因素之一。根據世界衛生組織2024年11月發布的論文，慢性阻塞性肺病（COPD）是全球重大健康挑戰，位居全球第四大死因，2021年死亡人數約350萬人死亡，佔全球整體的5%。這項負擔在低收入和中等收入國家 (LMIC) 尤為嚴重，其中近 90% 的 70 歲以下慢性阻塞性肺病相關死亡發生在這些國家。慢性阻塞性肺病的治療通常需要長期用藥方案，其中包括針對吞嚥困難或需要精確劑量的患者使用液體製劑。這對確保精確和受控劑量的口腔注射器產生了巨大的需求，特別是在慢性阻塞性肺病高發地區。

兒科手術數量的增加也推動了口腔注射器市場的成長。根據 Breaking Media, Inc. 2024 年 2 月發表的報導，美國每年對兒科患者進行近 400 萬例手術，凸顯了兒童的高醫療需求。然而，儘管有這個數字，但針對兒科的醫療解決方案仍有差距，因為許多外科創新歷來都專注於治療成人。對以兒科為重點的醫療護理的需求不斷增加，為包括口腔注射器在內的專用醫療設備創造了機會，以確保年輕患者的準確劑量，特別是在手術後的恢復期間。口服注射器能夠精確輸送藥物，降低與劑量不當相關的風險，並支持更好的兒科護理結果。隨著醫療行業專注於改善兒科護理，針對兒童需求量身定做的口服注射器的需求預計將會增加。這一趨勢凸顯了開發滿足兒科患者獨特需求的醫療解決方案以及確保術後和持續護理環境中安全有效的治療變得越來越重要。

口服注射器市場報告亮點

  • 按類型分類，透明口服注射器細分市場佔據最大佔有率，到 2024 年將達到 62.9%。慢性健康意識和注射器技術進步正在推動該領域的成長。
  • 按用途分類，可重複使用口服注射器市佔率最大，到 2024 年將達到 50.1%。慢性病盛行率的增加和製造商提供的技術先進的產品正在推動這一領域的成長。
  • 以最終用途分類，醫院領域所佔佔有率最大，到 2024 年將達到 56.3%。這是由於醫療保健環境中對準確可靠的藥物傳遞的需求不斷增加。醫院，尤其是提供兒科和新生兒護理的醫院，需要高品質的口腔注射器來準確、安全地計量液體藥物。
  • 2024年，北美將佔據口腔注射器市場40.6%的佔有率。由於慢性病盛行率增加、技術進步以及兒童癌症患者數量增加等多種因素，口腔注射器產業呈現持續成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章口服注射器市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 口服注射器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 口腔注射器市場：按類型估計和趨勢分析

  • 口服注射器市場：類型儀表板
  • 口服注射器市場：類型變異分析
  • 2018-2030 年口服注射器市場規模、預測與趨勢分析（按類型）
  • 透明口服注射器
  • 彩色口腔注射器

第5章口服注射器市場：依使用情況、估計值和趨勢分析

  • 口服注射器市場：使用儀表板
  • 口腔注射器市場：使用變化分析
  • 2018-2030 年口服注射器市場規模、預測與趨勢分析（按用途）
  • 可重複使用的口腔注射器
  • 免洗口腔注射器

第6章口服注射器市場：最終用途的估計和趨勢分析

  • 口服注射器市場：最終用途儀表板
  • 口服注射器市場：最終用途變化分析
  • 2018-2030 年口服注射器市場規模、預測與趨勢分析（依最終用途）
  • 醫院
  • 診所
  • 居家醫療

第7章口服注射器市場：按國家、類型、應用、最終用途、地區分類的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 2023年主要企業市場佔有率分析
    • Baxter
    • BD.
    • Medtronic
    • Terumo Medical Corporation
    • B. Braun SE
    • Thermo Fisher Scientific Inc.
    • Comar
    • CODAN
    • Neelkanth Polymer Industries
    • Changzhou Medical Appliances General Factory Co.,Ltd
Product Code: GVR-4-68038-704-9

Oral Syringes Market Growth & Trends:

The global oral syringes market size is expected to reach USD 1.05 billion by 2030, registering a CAGR of 6.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth are the growing prevalence of respiratory cases, the increasing prevalence of cancer incidence among the pediatric population, technological advancements, and government initiatives. The rising prevalence of COPD diseases is one of the factors boosting market growth. According to the WHO article published in November 2024, Chronic obstructive pulmonary disease (COPD) is a major global health challenge, ranking as the fourth leading cause of death worldwide and accounting for approximately 3.5 million deaths in 2021, or 5% of all global fatalities. The burden is particularly severe in low- and middle-income countries (LMICs), where nearly 90% of COPD-related deaths in individuals under 70 years occur. Managing COPD often involves long-term medication regimens, including liquid formulations for patients who face difficulty swallowing or require precise dosing. This creates a significant demand for oral syringes, which ensure accurate and controlled administration, especially in regions with high COPD prevalence.

The rising number of surgical procedures in children drives the growth of the oral syringes market. According to a Breaking Media, Inc. article published in February 2024, nearly four million surgical procedures are performed on pediatric patients in the United States each year, highlighting the significant healthcare needs of children. However, despite this large number, much surgical innovation has historically been geared toward adult treatments, leaving a gap in pediatric-specific medical solutions. This growing demand for pediatric-focused healthcare creates an opportunity for specialized medical devices, including oral syringes, to ensure accurate medication dosing in young patients, especially during post-surgical recovery. Oral syringes allow for precise delivery of medications, reducing the risks associated with improper dosing and supporting better outcomes in pediatric care. As the healthcare industry emphasizes improving pediatric care, the demand for oral syringes tailored to children's needs is expected to rise. This trend underscores the growing importance of developing medical solutions that meet the unique requirements of pediatric patients, ensuring safe and effective treatment in the postoperative and ongoing care settings.

Oral Syringes Market Report Highlights:

  • Based on type, the clear oral syringes segment held the largest share of 62.9% in 2024. The increase in chronic health awareness and the technological advancements in syringes drive the segment's growth.
  • Based on usage, the reusable oral syringes segment held the largest share of 50.1% in 2024. The increased prevalence of chronic diseases and technologically advanced products offered by the manufacturer drive the segment's growth.
  • Based on end-use, the hospitals segment held the most significant share of 56.3% in 2024, driven by the increasing demand for precise and reliable medication delivery in healthcare settings. Hospitals, particularly those providing pediatric and neonatal care, require high-quality oral syringes for accurate dosage and safe administration of liquid medications
  • North America dominated the oral syringes market with a share of 40.6% in 2024. The oral syringes industry exhibits consistent growth owing to several factors, including the increasing prevalence of chronic diseases, technological advancements, and rising pediatric cancer cases.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Usage
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market outlook
  • 2.2. Segment outlook
    • 2.2.1. Type outlook
    • 2.2.2. Usage outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Oral Syringes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing cancer cases among pediatric population
      • 3.2.1.2. Rising respiratory cases
      • 3.2.1.3. Rising number of surgical procedures in the children
      • 3.2.1.4. Technological advancement
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost compared to dose cups and droppers
  • 3.3. Oral Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Oral Syringes Market: Type Estimates & Trend Analysis

  • 4.1. Oral Syringes Market: Type Dashboard
  • 4.2. Oral Syringes Market: Type Movement Analysis
  • 4.3. Oral Syringes Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Clear Oral Syringes
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Colorful Oral Syringes
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Oral Syringes Market: Usage Estimates & Trend Analysis

  • 5.1. Oral Syringes Market: Usage Dashboard
  • 5.2. Oral Syringes Market: Usage Movement Analysis
  • 5.3. Oral Syringes Market Size & Forecasts and Trend Analysis, by Usage, 2018 to 2030 (USD Million)
  • 5.4. Reusable Oral Syringes
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Single Use Oral Syringes
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Oral Syringes Market: End Use Estimates & Trend Analysis

  • 6.1. Oral Syringes Market: End Use Dashboard
  • 6.2. Oral Syringes Market: End Use Movement Analysis
  • 6.3. Oral Syringes Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Homecare Settings
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Oral Syringes Market: Regional Estimates & Trend Analysis by Country, Type, Usage, End-use and Region

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Baxter
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. BD.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Medtronic
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Terumo Medical Corporation
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. B. Braun SE
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Thermo Fisher Scientific Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Comar
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. CODAN
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Neelkanth Polymer Industries
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Changzhou Medical Appliances General Factory Co.,Ltd
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Global oral syringes market, by type 2018 - 2030 (USD Million)
  • Table 3. Global oral syringes market, by usage 2018 - 2030 (USD Million)
  • Table 5. Global oral syringes market, by end-use, 2018 - 2030
  • Table 6. Global oral syringes market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 9. North America oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 10. North America oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 11. U.S. oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 12. U.S. oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 13. U.S. oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 14. Canada oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 15. Canada oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 16. Canada oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 17. Mexico oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 18. Mexico oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 19. Mexico oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 20. Europe oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 22. Europe oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 23. Europe oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 24. U.K. oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 25. U.K. oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 26. U.K. oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 27. Germany oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 28. Germany oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 29. Germany oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 30. France oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 31. France oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 32. France oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 33. Italy oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 34. Italy oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 35. Italy oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 36. Spain oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 37. Spain oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 38. Spain oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 39. Denmark oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 40. Denmark oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 41. Denmark oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 42. Sweden oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 43. Sweden oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 44. Sweden oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 45. Norway oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 46. Norway oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 47. Norway oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 52. Japan oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 53. Japan oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 54. Japan oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 55. China oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 56. China oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 57. China oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 58. India oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 59. India oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 60. India oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 61. Australia oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 62. Australia oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 63. Australia oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 64. Australia oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 65. Thailand oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 66. Thailand oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 67. Thailand oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 68. South Korea oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 69. South Korea oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 70. South Korea oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 71. Latin America oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 72. Latin America oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 73. Latin America oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 74. Latin America oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 75. Brazil oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 76. Brazil oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 77. Brazil oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 78. Argentina oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 79. Argentina oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 80. Argentina oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 81. MEA oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 82. MEA oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 83. MEA oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 84. MEA oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 85. South Africa oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 86. South Africa oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 87. South Africa oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 90. Saudi Arabia oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 91. UAE oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 92. UAE oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 93. UAE oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 94. Kuwait oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 95. Kuwait oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 96. Kuwait oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 97. Participant's overview
  • Table 98. Financial performance
  • Table 99. Key companies undergoing expansions
  • Table 100. Key companies undergoing acquisitions
  • Table 101. Key companies undergoing collaborations
  • Table 102. Key companies launching new product types
  • Table 103. Key companies undergoing partnerships
  • Table 104. Key companies undertaking other strategies

List of Figures

  • Fig. 1 Oral syringes market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot - I
  • Fig. 9 Segment snapshot -II
  • Fig. 10 Competitive landscape
  • Fig. 11 Oral syringes market dynamics
  • Fig. 12 Oral syringes market: PORTER's analysis
  • Fig. 13 Oral syringes market: PESTEL analysis
  • Fig. 14 Oral syringes market: Type dashboard
  • Fig. 15 Oral syringes market Type movement analysis
  • Fig. 16 Global clear oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 17 Global colorful oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 18 Oral syringes market: Usage dashboard
  • Fig. 19 Oral syringes market Usage movement analysis
  • Fig. 20 Global reusable oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 21 Global single use oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 22 Oral syringes market: End use dashboard
  • Fig. 23 Oral syringes market End use movement analysis
  • Fig. 24 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 25 Global clinics market, 2018 - 2030 (USD Million)
  • Fig. 26 Global homecare settings market, 2018 - 2030 (USD Million)
  • Fig. 27 Oral syringes market revenue, by region, 2024 & 2030, (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Canada oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Europe oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 UK oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Germany oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 France oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Italy oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Spain oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Norway oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Japan oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 China oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 India oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Australia oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 MEA oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 UAE oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 57 Heat map analysis
  • Fig. 58 Strategy mapping